Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)

NCT00028236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

NIH

Sponsor class

Conditions

Severe Combined Immunodeficiency

Interventions

DRUG: Gene-Transduced Autologous CD34+ Stem Cells

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)